| Impact of vaccination and early monoclonal antibody therapy on coronavirus disease 2019 outcomes in organ transplant recipients during the Omicron wave JT Solera, BG Árbol, A Alshahrani, I Bahinskaya, N Marks, A Humar, ... Clinical Infectious Diseases 75 (12), 2193-2200, 2022 | 49 | 2022 |
| Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA. 2 wave JT Solera, BG Árbol, I Bahinskaya, N Marks, A Humar, D Kumar American Journal of Transplantation 23 (1), 78-83, 2023 | 30 | 2023 |
| Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings VH Ferreira, JT Solera, Q Hu, VG Hall, BG Arbol, W Rod Hardy, R Samson, ... Nature Communications 13 (1), 4489, 2022 | 15 | 2022 |
| Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients JT Solera, M Ierullo, BG Arbol, F Mavandadnejad, A Kurtesi, F Qi, Q Hu, ... The Lancet Infectious Diseases 23 (8), e266-e267, 2023 | 14 | 2023 |
| Differential serum neutralisation of Omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab JT Solera, BG Arbol, VH Ferreira, A Kurtesi, Q Hu, M Ierullo, ... The Lancet Infectious Diseases 23 (5), 528-530, 2023 | 12 | 2023 |
| Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023 JT Solera, BG Árbol, A Mittal, V Hall, T Marinelli, I Bahinskaya, N Selzner, ... American Journal of Transplantation, 2024 | 3 | 2024 |
| COVID-19 reinfection has better outcomes than the first infection in solid organ transplant recipients JT Solera, BG Árbol, A Mittal, VG Hall, T Marinelli, I Bahinskaya, A Humar, ... Transplantation, 10.1097, 2023 | 2 | 2023 |
Javier Tomás Solera RalloChief Fellow, Ajmera Transplant Centre, University Health Network, Toronto, CanadaVerified email at uhn.ca
